Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spacers for Prostate Cancer Radiotherapy

Home  /  Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spacers for Prostate Cancer Radiotherapy

Patient group input requested for a new collaborative assessment on a medical device for rectum spacers for prostate cancer radiotherapy.

EUnetHTA deems patient input very important in the production of Collaborative Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patients or patient groups can help us understand the unique perspectives and experiences we aim to assess. They can describe advantages and disadvantages of medical treatments based on patients’ experiences and what patients value from a new treatment/procedure.

EUnetHTA recently started a new Collaborative Assessment on a medical device for the use of rectum spacers (e.g. spaceOAR) for prostate cancer radiotherapy. For this specific assessment, we are seeking for European and national patient organisations to provide an organisational perspective on the questions; the assessment and forms are English [1]. In all parts of this form the term “patient” refers to anyone living with the condition or who has experience with the condition for which the new medical device is indicated. The information provided will inform the scope of the assessment, e.g. on patient relevant outcomes or possible neglected outcomes, as well as on the burden of disease.

The questions EUnetHTA ask patients or patient organisations are similar to the HTAi questionnaire on patient engagement.

EUnetHTA strives to be transparent in the information used. Therefore, we commit ourselves to making all patient submissions publically available at our webpage, at the timing of publication of the project plan for this assessment. In due course, this can be found here. We will anonymise the data from individual patients prior to publication. Furthermore, our Collaborative Assessment report will document how the information from patients was considered in developing the scope of our EUnetHTA Collaborative Assessment.

If you are interested in submitting information, please go to the questionnaire below and submit your input by EOB, Friday 30th August, 2019.

Please see below for further guidance on how to complete this questionnaire. If you have any questions when completing this form, please contact EUnetHTA Joint Production lead partner, the Norwegian Institute of Public Health at WP4.LP_EUnetHTA.JA3@fhi.no

Many thanks for your valuable input!

 

CONSULTATION OPEN

CLICK HERE

Patient group input requested for a new Collaborative Assessment on a Medical Device for rectum spacers for prostate cancer radiotherapy.

 

[1] We are working on translating the questionnaire to national languages so that also individual patients can submit information. Unfortunately, this will not be possible for this specific assessment.

Your Information

To collect your information, we use a GDPR-compliant access tool called Crowdsignal that allows owners of quizzes, polls, and other surveys to safely field respondent information.

This tool allows respondents to look up and request the deletion of their responses and related personal information. Delete requests are accompanied by your email address and the country from which you are making the request.

A cookie is used to keep you logged into this page. It holds a randomly generated string that is also recorded on our servers. This then expires within an hour unless you navigate further around this page.

If, pending your review, you would like to request that your information be deleted, Crowdsignal will pass on your request to us. Your email address will be sent as part of this request response. You should reach out to us for any further inquiries about your personal information or responses.

Your IP address indicates you are making this request from inside the EU.

Review your submission HERE.